Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

multiple TAA-loaded dendritic cell vaccine

A dendritic cell (DC) vaccine in which autologous DCs are loaded with multiple tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon re-infusion into the patient, the antigen-pulsed DCs stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against the TAA-expressing tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	antigen-pulsed DCs MASCT-I multiple TAA-loaded DC vaccine multiple target antigen-stimulating cells-I
Abbreviation:	MASCT-I

multiple TAA-loaded dendritic cell vaccine

Search NCI's Drug Dictionary